These changes were reduced in EphA4‐KO tumor‐bearing mice without IGF1 administration and enhanced by IGF1 treatment (Fig. 5B‐1–3), although the IGF1 treatment was unable to enhance the change to the WT level (Fig. 5B‐3). This evidence concerns the gene EPHA4 and neoplasm.